Drug & intervention

lecanemab

RxCUI 2626143

Clinical trials11
Recruiting3
Related conditions11
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

11 shown
Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's BiomarkersNCT07688460 · 2026-07-10
RECRUITING
Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DIVA Study)NCT06530732 · 2024-07-01
RECRUITING
Cognitive Neurology Unit Clinical RegistryNCT05925621 · 2023-07-16
RECRUITING
Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD PathologyNCT07544953 · 2026-05-01
NOT_YET_RECRUITING
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's DiseaseNCT06602258 · 2024-09-30
ACTIVE_NOT_RECRUITING
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's DiseaseNCT06384573 · 2024-06-10
ACTIVE_NOT_RECRUITING
Feasibility of Lecanemab Registry and Clinical Outcome MeasuresNCT06285448 · 2024-01-02
ENROLLING_BY_INVITATION
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) TherapyNCT05469009 · 2022-07-14
ACTIVE_NOT_RECRUITING
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)NCT05269394 · 2021-12-22
ACTIVE_NOT_RECRUITING
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate AmyloidNCT04468659 · 2020-07-14
ACTIVE_NOT_RECRUITING
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001NCT01760005 · 2012-12-01
ACTIVE_NOT_RECRUITING

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.